051630 — CHINYANG CHEMICAL Balance Sheet
0.000.00%
- KR₩47bn
- KR₩46bn
- KR₩25bn
Annual balance sheet for CHINYANG CHEMICAL, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 3,786 | 4,146 | 6,018 | 1,070 | 36,898 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 5,556 | 2,944 | 4,102 | 2,788 | 1,769 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 12,228 | 8,762 | 11,972 | 5,861 | 39,628 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 25,319 | 21,103 | 26,591 | 37,549 | 35,976 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 38,259 | 33,655 | 44,569 | 49,908 | 82,069 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 8,046 | 5,125 | 6,509 | 6,627 | 4,989 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 10,653 | 8,263 | 9,828 | 17,340 | 43,290 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 27,605 | 25,392 | 34,741 | 32,568 | 38,779 |
Total Liabilities & Shareholders' Equity | 38,259 | 33,655 | 44,569 | 49,908 | 82,069 |
Total Common Shares Outstanding |